News

Top 10 Morpheus8 Questions Being Asked About This Skin Procedure

NEWPORT BEACH, CA / ACCESSWIRE / January 5, 2024 / Morpheus8 is an innovative esthetic procedure that has gained popularity…

2 years ago

Glidewell Publishes Inaugural Edition of Integrate(TM) Magazine

A new publication dedicated to making implant dentistry more accessible to all.NEWPORT BEACH, CA / ACCESSWIRE / January 5, 2024…

2 years ago

Spiden Announces Breakthrough in Non-Invasive Glucose Monitoring, Adds Key Executive Hires and Secures $15m in Additional Funding

PFÄFFIKON, SWITZERLAND / ACCESSWIRE / January 5, 2024 / Spiden, a pioneer in non-invasive biomarker monitoring technology, is thrilled to…

2 years ago

Nutriband Signs Commercial Development and Clinical Supply Agreement With Kindeva Drug Delivery for Aversa(TM) Fentanyl, an Abuse Deterrent Fentanyl Patch

ORLANDO, FL / ACCESSWIRE / January 5, 2024 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of transdermal…

2 years ago

AngioDynamics Reports Fiscal Year 2024 Second Quarter Financial Results; Revises Fiscal Year 2024 Guidance

Fiscal Year 2024 Second Quarter Highlights Net sales of $79.1 million increased 2.7% on a pro-forma basis compared to the…

2 years ago

Metrodora Institute Announces New Chief Scientific Officer

Rohit Gupta, a Nationally Recognized Scientist, Biobank and Data Expert, is Named as Metrodora Institute's New Chief Scientific Officer and…

2 years ago

Zen Dog Veterinary Care Expands Services to Westchester

NEW YORK, NY / ACCESSWIRE / January 5, 2024 / Zen Dog Veterinary Care, New York City's premier in-home pet…

2 years ago

CureVac Announces Positive Phase 2 Interim Data from COVID-19 Vaccine Development Program in Collaboration with GSK Providing Strong Validation of Proprietary Technology Platform

Head-to-head comparison with licensed bivalent mRNA-based comparator vaccine confirms competitive immune responses at lower doses and favorable tolerability profileMonovalent mRNA…

2 years ago

Standard BioTools Completes Merger with SomaLogic, Creating a Diversified and Scaled Leader in Life Sciences Tools

Establishes Leading Platform of Complementary Multi-omic Technologies with Enhanced Scale and Commercial Reach; Strengthened Balance Sheet to Self-Fund Future Growth…

2 years ago

Jasper Therapeutics Highlights Recent Accomplishments and Key Upcoming Milestones

- EU Clinical Trials authorized for Phase 1b/2a SPOTLIGHT and BEACON studies of briquilimab in CIndU and CSU, respectively -…

2 years ago